EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	738	523	1,088	119	415	100
Market Cap Growth	42.90%	-51.95%	811.96%	-71.25%	316.71%	-40.59%
Enterprise Value	527	292	958	8	334	125
Last Close Price	11.01	7.45	23.11	3.50	12.24	6.58
PS Ratio	13.72	12.08	23.64	2.88	11.23	2.89
PB Ratio	3.08	1.55	4.09	1.24	2.25	5.37
P/TBV Ratio	3.08	1.55	4.09	1.24	2.57	-
P/OCF Ratio	-	-	580.20	-	-	-
EV/Sales Ratio	10.15	6.75	20.82	0.21	9.05	3.62
Debt / Equity Ratio	0.10	0.07	0.02	0.48	0.21	2.22
Asset Turnover	0.17	0.11	0.17	0.19	0.21	0.42
Inventory Turnover	58.46	43.12	20.06	17.83	8.06	6.22
Quick Ratio	7.73	7.58	5.25	4.64	9.72	3.65
Current Ratio	8.00	7.82	5.45	5.00	10.05	4.24
Return on Equity (ROE)	-73.95%	-43.42%	-39.04%	-72.84%	-57.58%	-337.87%
Return on Assets (ROA)	-37.79%	-23.57%	-17.52%	-22.24%	-19.46%	-28.30%
Return on Capital (ROIC)	-45.33%	-28.88%	-22.64%	-26.94%	-24.40%	-39.32%
Earnings Yield	-23.11%	-25.04%	-6.51%	-85.72%	-14.08%	-45.60%
FCF Yield	-25.57%	-24.92%	-0.15%	-56.29%	-12.11%	-14.86%
Buyback Yield / Dilution	-38.62%	-44.71%	-4.25%	-29.76%	-124.04%	-23.06%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q